Specificity of antibody-targeted drugs.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F97%3A53010165" target="_blank" >RIV/61388971:_____/97:53010165 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Specificity of antibody-targeted drugs.
Original language description
It has been previously demonstrated that antibody-targeted N-(2-hydroxypropyl)methacrylamide copolymers containing doxorubicin can have greater antitumor effect in vivo in animal models than drug in free form.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
EC - Immunology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GV307%2F96%2FK226" target="_blank" >GV307/96/K226: New macromolecular systems for targeted delivery of biological active compounds in the living organism</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
1997
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials.
ISBN
—
ISSN
—
e-ISSN
—
Number of pages
2
Pages from-to
105-106
Publisher name
Controlled Release Society
Place of publication
Stockholm
Event location
Stockholm [SE]
Event date
Jun 15, 1997
Type of event by nationality
WRD - Celosvětová akce
UT code for WoS article
—